Type of Presentation: Oral presentation
Topics: pre-mRNA splicing, RNA splicing, RNA structure, Antisense oligos, disease

Public Summary

Discovery of antisense oligonucleotides (ASOs) that rescue RNA splicing of an array of Hemophilia A (HA) linked pathogenic variants by targeting an inhibitory RNA structure. These findings reveal a rationale for developing a RNA-based therapy for HA.